1 Min Read
Dec 30 (Reuters) - OBI Pharma :
* Says it signed a letter of intent with AbProtix, Inc. to acquire 70 percent stake in AP Biosciences via new share issuance
Source text in Chinese: goo.gl/6IOwD7
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.